Urinary proteomics employing capillary electrophoresis coupled to mass spectrometry in the monitoring of patients after stem cell transplantation

Methods in Molecular Biology

Volumn 1109, Issue , 2014, Pages 293-306

  Weissinger, Eva M ^a   Mullen, William ^b   Albalat, Amaya ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Capillary electrophoresis; Clinical diagnosis; Hematopoietic stem cell transplantation; Mass spectrometry; Polypeptide; Proteomics

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROSPRAY MASS SPECTROMETRY; GRAFT VERSUS HOST REACTION; HUMAN; IATROGENIC DISEASE; MASS SPECTROMETER; ONLINE SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS;

BIOLOGICAL MARKERS; ELECTROPHORESIS, CAPILLARY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MASS SPECTROMETRY; PEPTIDES; PROTEINURIA; PROTEOME; PROTEOMICS;

EID: 84934444901     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-9437-9_15     Document Type: Article

References (35)

1. Anderson NL, Anderson NG (1998) Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 19:1853-1861
2. Kaiser T, Kamal H, Rank A et al (2004) Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 104:340-349
3. Weissinger EM, Schiffer E, Hertenstein B et al (2007) Proteomic patterns predict acute graft-versus- host disease after allogeneic hematopoietic stem cell transplantation. Blood 109:5511-5519
4. Decramer S, de Gonzalez PA, Breuil B et al (2008) Urine in clinical proteomics. Mol Cell Proteomics 7:1850-1862
5. Mischak H, Coon JJ, Novak J et al (2009) Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev 8:703-724
6. Mullen W, Albalat A, Gonzalez J et al (2012) Performance of different separation methods interfaced in the same MS-reflection TOF detector: a comparison of performance between CE versus HPLC for biomarker analysis. Electrophoresis 33:567-574
7. Mischak H, Allmaier G, Apweiler R et al (2010) Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2:46ps42
8. Picotti P, Aebersold R (2012) Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 9:555-566
9. Kaiser T, Wittke S, Just I et al (2004) Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use. Electrophoresis 25:2044-2055
10. Schiffer E, Mischak H, Novak J (2006) High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS. Proteomics 6:5615-5627
11. Siwy J, Mullen W, Golovko I, Franke J, Zurbig P (2011) Human urinary peptide database for multiple disease biomarker discovery. Proteomics Clin Appl 5:367-374
12. Stalmach A, Albalat A, Mullen W, Mischak H (2013) Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications. Electrophoresis 34(11):1452-1464
13. Mischak H, Schanstra JP (2011) CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin Appl 5:9-23
14. Schiffer E, Liabeuf S, Lacroix C et al (2011) Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysis. J Hypertens 29:783-790
15. Jahn H, Wittke S, Zurbig P et al (2011) Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers. PLoS One 6:e26540
16. Kaiser T, Hermann A, Kielstein JT et al (2003) Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids. J Chromatogr A 1013:157-171
17. Jiang H, Schiffer E, Song Z et al (2008) Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc Natl Acad Sci U S A 105:11299-11304
18. Mischak H, Vlahou A, Ioannidis JP (2013) Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience. Clin Biochem 46:432-443
19. Zurbig P, Renfrow MB, Schiffer E et al (2006) Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform- independent separation. Electrophoresis 27:2111-2125
20. Mischak H, Kolch W, Aivalotis M et al (2010) Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin Appl 4:464-478
21. Jantos-Siwy J, Schiffer E, Brand K et al (2009) Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J Proteome Res 8:268-281
22. Neuhoff N, Kaiser T, Wittke S et al (2004) Mass spectrometry for the detection of differentially expressed proteins: a comparison of surfaceenhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid Commun Mass Spectrom 18:149-156
23. Good DM, Zurbig P, Argiles A et al (2010) Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 9:2424-2437
24. Dakna M, Harris K, Kalousis A et al (2010) Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC Bioinformatics 11:594
25. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B (Methodological) 57:125-133
26. Mischak H (2012) How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS. Proteomics Clin Appl 6:437-442
27. Mischak H, Ioannidis JP, Argiles A et al (2012) Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 42:1027-1036
28. Henzel WJ, Watanabe C, Stults JT (2003) Protein identification: the origins of peptide mass fingerprinting. J Am Soc Mass Spectrom 14:931-942
29. Chalmers MJ, Mackay CL, Hendrickson CL et al (2005) Combined top-down and bottomup mass spectrometric approach to characterization of biomarkers for renal disease. Anal Chem 77:7163-7171
30. Theodorescu D, Fliser D, Wittke S et al (2005) Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 26:2797-2808
31. Belder D, Deege A, Husmann H, Kohler F, Ludwig M (2001) Cross-linked poly(vinyl alcohol) as permanent hydrophilic column coating for capillary electrophoresis. Electrophoresis 22:3813-3818
32. Johannesson N, Wetterhall M, Markides KE, Bergquist J (2004) Monomer surface modifications for rapid peptide analysis by capillary electrophoresis and capillary electrochromatography coupled to electrospray ionization- mass spectrometry. Electrophoresis 25:809-816
33. Liu CY (2001) Stationary phases for capillary electrophoresis and capillary electrochromatography. Electrophoresis 22:612-628
34. Ullsten S, Zuberovic A, Wetterhall M et al (2004) A polyamine coating for enhanced capillary electrophoresis-electrospray ionizationmass spectrometry of proteins and peptides. Electrophoresis 25:2090-2099
35. Mischak H, Delles C, Klein J, Schanstra JP (2010) Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application. Adv Chronic Kidney Dis 17:493-506